SIRT3: Striking at the heart of aging.

作者: Yufei Liu , Dan Zhang , Danica Chen

DOI: 10.18632/AGING.100256

关键词:

摘要: Ever since the realization that aging is a regulated process, intense research has gone into uncovering key players underlying its regulation. Among most intriguing molecular factors have been uncovered are sirtuins, family of NAD+-dependent deacetylases implicated in lifespan extension model organisms ranging from yeast to flies[1]. Mammals contain seven members sirtuin family, SIRT1-7, which SIRT1 extensively characterized. Although exact role sirtuins mammalian awaits further elucidation, barrage recent studies shown mitochondrial SIRT3 an important play warding off vicissitudes aging. In previous issue Aging, Hafner et al.(2010) add growing body evidence by showing mice lacking develop severe age-related pathologies heart [2]. Aging characterized hypertrophy and fibrosis, although causes unknown. Employing SIRT3−/− mice, al. present linking these phenotypes dysfunction SIRT3[2]. The authors show hearts more prone less resistant stress. They also note mitochondria significantly susceptible swelling, hallmark permeability transition pore (mPTP), multi-protein complex, thought be one main culprits driving pathology mitochondria[3]. Thus, inhibition mPTP could potentially major therapeutic value. found interacts with deacetylates cyclophilin D (CypD), component target prescription drug cyclosporine A (CsA) [4]. Interestingly, lysine residue on CypD targeted adjacent CsA binding site, raising possibility deacetylation might regulate function. Whereas inhibits structurally-related cyclophilins, leading suppression immune system, findings open up tantalizing targeting specifically suppress pernicious effects CypD. This study combined work Someya (2010), Kim Sundaresan (2009) can delay onset multiple tissues [2,5-7]. comes heels Qiu Tao (2010) implicating protection against oxidative stress, cause pathologies[6,8,9]. One targets uncovered, antioxidant superoxide dismutase 2 (SOD2), linked numerous longevity models. strong case built for as protector ravages However, whether actually extend still Also, while activity decrease age due lower levels NAD+, only apparent when older [2,10]. It mystery why phenotypically normal they young. Much remains done understand plays but floodgates opened, emerging increasingly attractive small molecule activators healthspan or even lifespan.

参考文章(10)
Haiyan Jiang, Hyun-Seok Kim, Charles Robb Flynn, Salisha Hill, W. Hayes McDonald, Alicia K. Olivier, Douglas R. Spitz, David Gius, Randa Tao, Mitchell C. Coleman, J. Daniel Pennington, Ozkan Ozden, Seong-Hoon Park, Sirt3-Mediated Deacetylation of Evolutionarily Conserved Lysine 122 Regulates MnSOD Activity in Response to Stress Molecular Cell. ,vol. 40, pp. 893- 904 ,(2010) , 10.1016/J.MOLCEL.2010.12.013
Nagalingam R Sundaresan, Madhu Gupta, Gene Kim, Senthilkumar B Rajamohan, Ayman Isbatan, Mahesh P Gupta, None, Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice Journal of Clinical Investigation. ,vol. 119, pp. 2758- 2771 ,(2009) , 10.1172/JCI39162
Gizem Donmez, Leonard Guarente, Aging and disease: connections to sirtuins Aging Cell. ,vol. 9, pp. 285- 290 ,(2010) , 10.1111/J.1474-9726.2010.00548.X
Xiaolei Qiu, Katharine Brown, Matthew D. Hirschey, Eric Verdin, Danica Chen, Calorie Restriction Reduces Oxidative Stress by SIRT3-Mediated SOD2 Activation Cell Metabolism. ,vol. 12, pp. 662- 667 ,(2010) , 10.1016/J.CMET.2010.11.015
Angela V. Hafner, Jing Dai, Ana P. Gomes, Chun-Yang Xiao, Carlos M. Palmeira, Anthony Rosenzweig, David A. Sinclair, Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy Aging (Albany NY). ,vol. 2, pp. 914- 923 ,(2010) , 10.18632/AGING.100252
Shinichi Someya, Wei Yu, William C. Hallows, Jinze Xu, James M. Vann, Christiaan Leeuwenburgh, Masaru Tanokura, John M. Denu, Tomas A. Prolla, Sirt3 Mediates Reduction of Oxidative Damage and Prevention of Age-Related Hearing Loss under Caloric Restriction Cell. ,vol. 143, pp. 802- 812 ,(2010) , 10.1016/J.CELL.2010.10.002
D. B. Zorov, M. Juhaszova, Y. Yaniv, H. B. Nuss, S. Wang, S. J. Sollott, Regulation and pharmacology of the mitochondrial permeability transition pore Cardiovascular Research. ,vol. 83, pp. 213- 225 ,(2009) , 10.1093/CVR/CVP151
David B. Lombard, Frederick W. Alt, Hwei-Ling Cheng, Jakob Bunkenborg, Ryan S. Streeper, Raul Mostoslavsky, Jennifer Kim, George Yancopoulos, David Valenzuela, Andrew Murphy, Yinhua Yang, Yaohui Chen, Matthew D. Hirschey, Roderick T. Bronson, Marcia Haigis, Leonard P. Guarente, Robert V. Farese, Sherman Weissman, Eric Verdin, Bjoern Schwer, Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Molecular and Cellular Biology. ,vol. 27, pp. 8807- 8814 ,(2007) , 10.1128/MCB.01636-07
Hyun-Seok Kim, Krish Patel, Kristi Muldoon-Jacobs, Kheem S. Bisht, Nukhet Aykin-Burns, J. Daniel Pennington, Riet van der Meer, Phuongmai Nguyen, Jason Savage, Kjerstin M. Owens, Athanassios Vassilopoulos, Ozkan Ozden, Seong-Hoon Park, Keshav K. Singh, Sarki A. Abdulkadir, Douglas R. Spitz, Chu-Xia Deng, David Gius, SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell. ,vol. 17, pp. 41- 52 ,(2010) , 10.1016/J.CCR.2009.11.023
Peter Waldmeier, Kaspar Zimmermann, Ting Qian, Marina Tintelnot-Blomley, John Lemasters, Cyclophilin D as a drug target. Current Medicinal Chemistry. ,vol. 10, pp. 1485- 1506 ,(2003) , 10.2174/0929867033457160